{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T20:05:43Z","timestamp":1720382743068},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.leukres.2017.01.031","type":"journal-article","created":{"date-parts":[[2017,2,5]],"date-time":"2017-02-05T02:45:34Z","timestamp":1486262734000},"page":"82-87","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts"],"prefix":"10.1016","volume":"56","author":[{"given":"Kamila","family":"Janusz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"del Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Ab\u00e1igar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Collado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ivars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Valiente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"D\u00edez-Campelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo del","family":"Ca\u00f1izo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas Mar\u00eda","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.leukres.2017.01.031_bib0005","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"111","author":"Nimer","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2017.01.031_bib0010","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ajh.24102","article-title":"Myelodysplastic syndromes: 2015 update on diagnosis, risk-stratification and management","volume":"90","author":"Garcia-Manero","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2017.01.031_bib0015","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.031_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beha.2014.01.001","article-title":"Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes","volume":"26","author":"Itzykson","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"22","key":"10.1016\/j.leukres.2017.01.031_bib0025","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.leukres.2017.01.031_bib0030","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2017.01.031_bib0035","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.leukres.2017.01.031_bib0040","volume":"Vol. 2","author":"Swerdlow","year":"2008"},{"issue":"2","key":"10.1016\/j.leukres.2017.01.031_bib0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.leukres.2017.01.031_bib0050","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"7367","key":"10.1016\/j.leukres.2017.01.031_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.leukres.2017.01.031_bib0060","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.leukres.2012.08.015","article-title":"Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts","volume":"36","author":"Cui","year":"2012","journal-title":"Leuk. Res."},{"issue":"14","key":"10.1016\/j.leukres.2017.01.031_bib0065","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","article-title":"Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis","volume":"119","author":"Makishima","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2017.01.031_bib0070","doi-asserted-by":"crossref","first-page":"e0126555","DOI":"10.1371\/journal.pone.0126555","article-title":"Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts","volume":"10","author":"del Rey","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.031_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.beha.2013.09.005","article-title":"Refractory anemia with ring sideroblasts","volume":"26","author":"Malcovati","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2017.01.031_bib0080","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.leukres.2017.01.031_bib0085","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","article-title":"Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms","volume":"118","author":"Malcovati","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2017.01.031_bib0090","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/leu.2011.155","article-title":"The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories","volume":"25","author":"Kohlmann","year":"2011","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2017.01.031_bib0095","doi-asserted-by":"crossref","first-page":"e0143073","DOI":"10.1371\/journal.pone.0143073","article-title":"A low frequency of losses in 11q chromosome is associated with better outcome and lower rate of genomic mutations in patients with chronic lymphocytic leukemia","volume":"10","author":"Hernandez","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.leukres.2017.01.031_bib0100","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1002\/ajh.23734","article-title":"SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution","volume":"89","author":"Lin","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2017.01.031_bib0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Tsiatis","year":"2010","journal-title":"J. Mol. Diagn."},{"issue":"4","key":"10.1016\/j.leukres.2017.01.031_bib0110","first-page":"177","article-title":"Next-generation sequencing for cancer diagnostics: a practical perspective","volume":"32","author":"Meldrum","year":"2011","journal-title":"Clin. Biochem. Rev."},{"issue":"2","key":"10.1016\/j.leukres.2017.01.031_bib0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","article-title":"SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts","volume":"126","author":"Malcovati","year":"2015","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.leukres.2017.01.031_bib0120","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.leukres.2017.01.031_bib0125","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","article-title":"Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes","volume":"119","author":"Damm","year":"2012","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.leukres.2017.01.031_bib0130","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","article-title":"Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes","volume":"119","author":"Thol","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.031_bib0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.28011","article-title":"Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors","volume":"133","author":"Je","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.031_bib0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng.1031","article-title":"Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes","volume":"44","author":"Graubert","year":"2012","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.leukres.2017.01.031_bib0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2013-01-480970","article-title":"Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms","volume":"122","author":"Przychodzen","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.031_bib0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/leu.2014.144","article-title":"PRPF8 defects cause missplicing in myeloid malignancies","volume":"29","author":"Kurtovic-Kozaric","year":"2015","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.leukres.2017.01.031_bib0155","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","article-title":"SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes","volume":"120","author":"Visconte","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2017.01.031_bib0160","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/leu.2011.232","article-title":"SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts","volume":"26","author":"Visconte","year":"2012","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T21:10:59Z","timestamp":1601586659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617300425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":32,"alternative-id":["S0145212617300425"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.031","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}